Загрузка...

DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

The recently approved drugs 5-azacitidine and 5-aza-2′-deoxyazacytidine are in wide clinical use for the treatment of myelodysplastic syndrome of all types and chronic myelomonocytic leukemia. These agents were developed based upon an understanding of the importance of epigenetic changes in malignan...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Griffiths, Elizabeth A., Gore, Steven D.
Формат: Artigo
Язык:Inglês
Опубликовано: 2008
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2234265/
https://ncbi.nlm.nih.gov/pubmed/18179966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2007.11.007
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!